Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy of alogliptin compared to placebo when
given alone or as add-on therapy to metformin or add-on to pioglitazone (with or without
metformin).